Skip to main content

Table 4 Treatment-related characteristics of pediatric malignant bone tumor patients

From: Patterns and treatment outcomes of primary bone tumors in children treated at tertiary referral hospital, Ethiopia

Variable

Frequency

Percent (%)

Treatment initiated

 No

27

28.4

 Yes

68

71.6

Therapeutic intent (n = 68)

 Curative

44

64.7

 Palliative

24

35.3

Treatment completed (n = 68)

 No

36

52.9

 Yes

32

47.1

Reason for not completing treatment (n = 35)

 Death

5

14.3

 Lost to follow up

18

51.4

 Left against medical advice

9

25.7

 Palliative care (due to progression)

3

8.6

Type of protocol (n = 67)

 OS1&OS2 protocol

42

61.8

 VCD/IE protocol

15

22.1

 VCD protocol

4

5.9

 Other (VAC, PO palliative)

7

10.3

  1. OS1 Cisplatin and doxorubicin, OS2 Cyclophosphamide and Etoposide, VCD/IE Vincristine cyclophosphamide doxorubicin ifosfamide and etoposide, VAC Vincristine Actinomycin and cyclophosphamide